Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06053112Not ApplicableActive Not Recruiting

The Trial of a New Infant Formula in Healthy Term Chinese Infants

Role: lead

NCT04749290Not ApplicableCompleted

Effects of an Infant Formula on Growth, Safety and Efficacy for Healthy Term Infants

Role: collaborator

NCT05123651Not ApplicableCompleted

Research on the Characteristics and Application of Lactobacillus Rhamnosus X253 as Oral Probiotics

Role: lead

NCT03416595Not ApplicableUnknown

A Study on Efficacy of Feeding N1115 Probiotic Supplement to Young Children

Role: lead

All 4 trials loaded